Lido Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.95M | Hold |
15,700
| – | – | 0.01% | 565 |
|
|
2026
Q1 | $3.41M | Buy |
15,700
+7,000
| +80% | +$1.55M | 0.01% | 545 |
|
|
2025
Q4 | $1.99M | Hold |
8,700
| – | – | 0.01% | 726 |
|
|
2025
Q3 | $2.01M | Buy |
8,700
+1,400
| +19% | +$285K | 0.01% | 685 |
|
|
2025
Q2 | $1.36M | Buy |
7,300
+2,300
| +46% | +$427K | 0.01% | 722 |
|
|
2025
Q1 | $1.05M | Hold |
5,000
| – | – | ﹤0.01% | 761 |
|
|
2024
Q4 | $889K | Sell |
5,000
-2,100
| -30% | -$386K | ﹤0.01% | 805 |
|
|
2024
Q3 | $1.4M | Hold |
7,100
| – | – | 0.01% | 584 |
|
|
2024
Q2 | $1.22M | Sell |
7,100
-7,600
| -52% | -$1.26M | 0.01% | 581 |
|
|
2024
Q1 | $2.68M | Hold |
14,700
| – | – | 0.02% | 377 |
|
|
2023
Q4 | $2.28M | Hold |
14,700
| – | – | 0.02% | 388 |
|
|
2023
Q3 | $2.19M | Buy |
14,700
+2,100
| +17% | +$308K | 0.02% | 359 |
|
|
2023
Q2 | $1.7M | Sell |
12,600
-400
| -3% | -$58.7K | 0.01% | 405 |
|
|
2023
Q1 | $2.07M | Hold |
13,000
| – | – | 0.02% | 336 |
|
|
2022
Q4 | $2.1M | Sell |
13,000
-4,500
| -26% | -$690K | 0.03% | 288 |
|
|
2022
Q3 | $2.35M | Buy |
17,500
+4,500
| +35% | +$646K | 0.03% | 233 |
|
|
2022
Q2 | $1.99M | Sell |
13,000
-100
| -0.8% | -$15.3K | 0.03% | 236 |
|
|
2022
Q1 | $2.12M | Sell |
13,100
-200
| -2% | -$29.1K | 0.02% | 252 |
|
|
2021
Q4 | $1.8M | Hold |
13,300
| – | – | 0.02% | 296 |
|
|
2021
Q3 | $1.43M | Hold |
13,300
| – | – | 0.02% | 324 |
|
|
2021
Q2 | $1.5M | Sell |
13,300
-100
| -0.7% | -$11.3K | 0.02% | 305 |
|
|
2021
Q1 | $1.45M | Buy |
13,400
+5,200
| +63% | +$556K | 0.03% | 276 |
|
|
2020
Q4 | $878K | Sell |
8,200
-900
| -10% | -$86.5K | 0.02% | 342 |
|
|
2020
Q3 | $797K | Hold |
9,100
| – | – | 0.02% | 302 |
|
|
2020
Q2 | $893K | Sell |
9,100
-3,000
| -25% | -$264K | 0.03% | 257 |
|
|
2020
Q1 | $921K | Hold |
12,100
| – | – | 0.04% | 239 |
|
|
2019
Q4 | $1.07M | Hold |
12,100
| – | – | 0.04% | 250 |
|
|
2019
Q3 | $916K | Hold |
12,100
| – | – | 0.05% | 234 |
|
|
2019
Q2 | $879K | Buy |
12,100
+6,000
| +98% | +$472K | 0.05% | 210 |
|
|
2019
Q1 | $491K | Buy |
+6,100
| New | +$499K | 0.03% | 290 |
|
Other funds holding ABBV
Lido Advisors's ABBV Position: Q2 2026 in Review
Lido Advisors increased its AbbVie (ABBV) stake by 6.3% in Q2 2026, buying an estimated $5.86M and bringing the position to 459,683 shares worth $116M. The position accounts for 0.31% of the portfolio, ranked #46.
Lido Advisors first reported a position in ABBV in Q1 2016 and has held it in 42 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Lido Advisors held 459,683 shares of AbbVie worth $116M as of Q2 2026.
- Lido Advisors bought 27,218 AbbVie shares in Q2 2026, an estimated $5.86M.
- AbbVie made up 0.31% of Lido Advisors's portfolio in Q2 2026, its #46 holding.
- Lido Advisors first reported a position in AbbVie in Q1 2016 and has held it in 42 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.